Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF

Since the survival of ingrowing cells in biomaterials for regenerative processes largely depends on the supply of nutrients and oxygen, angiogenesis plays an important role in the development of new materials for tissue engineering. In this study we investigated the possibility of enhancing the angiogenic properties of collagen matrices by covalent incorporation of the vascular endothelial growth factor (VEGF). In a previous paper we already reported the use of homo- and heterobifunctional cross-linking agents for modifying collagen matrices [1].In the present work the angiogenic growth factor was linked to the collagen with the homobifunctional cross-linker disuccinimidyldisuccinatepolyethyleneglycol (SS-PEG-SS) in a two step procedure. The efficiency of the first reaction step–the reaction of SS-PEG-SS with VEGF—was evaluated by western blot analysis. After 10 minutes virtually all of the dimeric molecules VEGF were on average modified by conjugation with 1 cross-linking molecule. The biological activity of the conjugate was investigated by exposing endothelial cells to non-modified VEGF and to VEGF conjugated to the cross-linker. The conjugation only had a limited effect on the mitogenic activity of VEGF. We therefore applied the cross-linking reaction to the VEGF-collagen system. In a first approach the changes were evaluated by the in vitro exposure of HUVECs to non-modified matrices, to matrices in which the VEGF was simply admixed and to matrices in which the VEGF was covalently incorporated. The angiogenic properties were evaluated in vivo with the chorioallantois membrane model. In this assay the chorioallantois membrane of the chicken embryo was exposed to the same set of matrices. The covalent incorporation of VEGF has a small but significant effect both on the formation of microvessels in the chorioallantois membrane and the tissue ingrowth into the implant. The covalent incorporation of angiogenic growth factors may thus be considered as a promising approach for enhancing the angiogenic capabilities of collagen matrices. Also the cross-linking with the homobifunctional cross-linking agent has a positive effect on the angiogenic potential of the collagen matrices.

[1]  J. Veerkamp,et al.  Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. , 2002, Journal of biomedical materials research.

[2]  G. Downing,et al.  Modification of native collagen reduces antigenicity but preserves cell compatibility , 2000, Biotechnology and bioengineering.

[3]  L. Orci,et al.  Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. , 1991, Biochemical and biophysical research communications.

[4]  D. Klee,et al.  The chorioallantoic membrane of the chick embryo as a simple model for the study of the angiogenic and inflammatory response to biomaterials , 2001, Journal of materials science. Materials in medicine.

[5]  J. Hubbell,et al.  Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro. , 2001, Microvascular research.

[6]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[7]  J. McPherson,et al.  A comparative study of the biologic and immunologic response to medical devices derived from dermal collagen. , 1986, Journal of biomedical materials research.

[8]  Kayla J Bayless,et al.  Molecular basis of endothelial cell morphogenesis in three‐dimensional extracellular matrices , 2002, The Anatomical record.

[9]  Anthony Atala,et al.  Systems for therapeutic angiogenesis in tissue engineering , 2000, World Journal of Urology.

[10]  Yasuo Suzuki,et al.  Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release. , 2003, Journal of biomedical materials research. Part A.

[11]  J. Feijen,et al.  Endothelial cell seeding of (heparinized) collagen matrices: effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[12]  A A Poot,et al.  Binding and release of basic fibroblast growth factor from heparinized collagen matrices. , 2001, Biomaterials.

[13]  Anthony Atala,et al.  Principals of neovascularization for tissue engineering. , 2002, Molecular aspects of medicine.

[14]  N. Pallua,et al.  The use of bifunctional polyethyleneglycol derivatives for coupling of proteins to and cross-linking of collagen matrices , 2002, Journal of materials science. Materials in medicine.

[15]  A Vacca,et al.  The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. , 1996, The International journal of developmental biology.

[16]  H. Bentz,et al.  Improved local delivery of TGF-beta2 by binding to injectable fibrillar collagen via difunctional polyethylene glycol. , 1998, Journal of biomedical materials research.